Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug utilisation review and pharmacoeconomics: interaction after parallel development?

× No keyword cloud information.

82 in total

Review 1. The Canadian health care system: a model for American to emulate?

Authors: C D Naylor
Journal: Health Econ Date: 1992-04 Impact factor: 3.046

2. Rising research and development costs for new drugs in a cost containment environment.

Authors: J A DiMasi
Journal: Pharmacoeconomics Date: 1992 Impact factor: 4.981

3. To prescribe or not to prescribe: on the regulation of pharmaceuticals in less developed countries.

Authors: J S Hammer
Journal: Soc Sci Med Date: 1992-05 Impact factor: 4.634

4. Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: A P Maggioni; M G Franzosi; M L Farina; E Santoro; M G Celani; S Ricci; G Tognoni
Journal: BMJ Date: 1991-06-15

5. Economics, health, and the economics of health.

Authors: C Normand
Journal: BMJ Date: 1991 Dec 21-28

6. A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countries.

Authors: B Leese; J Hutton; A Maynard
Journal: Pharmacoeconomics Date: 1992-05 Impact factor: 4.981

7. Drug promotion: stealth, wealth, and safety.

Authors:
Journal: Lancet Date: 1993-06-12 Impact factor: 79.321

8. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors: M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal: N Engl J Med Date: 1992-09-03 Impact factor: 91.245

Review 9. National Education Programs Working Group report on the management of patients with hypertension and high blood cholesterol.

Authors:
Journal: Ann Intern Med Date: 1991-02-01 Impact factor: 25.391

10. Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: a placebo-controlled arteriographic coronary recanalization study.

Authors: A D Timmis; B Griffin; J C Crick; E Sowton
Journal: J Am Coll Cardiol Date: 1987-07 Impact factor: 24.094

7 in total

Review 1. Economic impact of cost-containment strategies in third party programmes in the US. Part II.

Authors: C M Kozma; R M Schulz; W M Dickson; J T Dye; E R Cox; D A Holdford; L Michael; W N Yates; T L Young
Journal: Pharmacoeconomics Date: 1993-09 Impact factor: 4.981

2. The cost effectiveness of drug utilisation review in an outpatient setting.

Authors: D H Kreling; D A Mott
Journal: Pharmacoeconomics Date: 1993-12 Impact factor: 4.981

Review 3. Drug utilisation studies as tools in health economics.

Authors: J A Sacristán; J Soto
Journal: Pharmacoeconomics Date: 1994-04 Impact factor: 4.981

4. Drugs, money and society.

Authors: T Walley
Journal: Br J Clin Pharmacol Date: 1995-04 Impact factor: 4.335

5. The role of pharmacoeconomics in disease management. A pharmaceutical benefit management company perspective.

Authors: N Thomas
Journal: Pharmacoeconomics Date: 1996 Impact factor: 4.981

Review 6. Antimicrobial drug utilisation in hospitals in Italy and other European countries.

Authors: L Guglielmo; R Leone; U Moretti; A Conforti; G P Velo
Journal: Infection Date: 1994 Impact factor: 3.553

7. How informed general practitioners manage mild hypertension: a survey of readers of drug bulletins in 7 countries. International Society of Drug Bulletins (ISDB).

Authors: F Avanzini; G Tognoni; C Alli; F Colombo; A Herxheimer
Journal: Eur J Clin Pharmacol Date: 1996 Impact factor: 2.953

7 in total